We are live on ! Find out more
Commonwealth Equity Services

Commonwealth Equity Services Portfolio holdings

AUM $71.6B
1-Year Est. Return 21.08%
This Fund
S&P 500
This Quarter Est. Return
-5.37%
1 Year Est. Return
+21.08%
3 Year Est. Return
+64.42%
5 Year Est. Return
+73.55%
10 Year Est. Return
+239.11%
AUM
$38.8B
AUM Growth
+$429M
Cap. Flow
+$1.27B
Cap. Flow %
3.28%
Top 10 Hldgs %
19.52%
Holding
3,828
New
166
Increased
1,856
Reduced
1,460
Closed
165

Sector Composition

Rank Sector Weight
1 Technology 13.26%
2 Financials 5.74%
3 Healthcare 5.13%
4 Consumer Discretionary 4.37%
5 Consumer Staples 3.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARDX icon
3576
Ardelyx
ARDX
$1.24B
$20K ﹤0.01%
17,100
CARM
3577
DELISTED
Carisma Therapeutics
CARM
$20K ﹤0.01%
2,469
GYRE icon
3578
Gyre Therapeutics
GYRE
$662M
$20K ﹤0.01%
5,402
+4,069
+305% +$51.7K
OTLK icon
3579
Outlook Therapeutics
OTLK
$264M
$20K ﹤0.01%
826
SQFT icon
3580
Presidio Property Trust
SQFT
$3.01M
$20K ﹤0.01%
1,624
+11
+0.7% +$295
ALZN icon
3581
Alzamend Neuro
ALZN
$5.06M
$19K ﹤0.01%
12
DMRA
3582
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.77B
$19K ﹤0.01%
+407
New +$20.6K
GTBP icon
3583
GT Biopharma
GTBP
$11.7M
$19K ﹤0.01%
372
TTOO
3584
DELISTED
T2 Biosystems, Inc
TTOO
$19K ﹤0.01%
34
+10
+42% +$6.58K
HOFV
3585
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
$18K ﹤0.01%
1,547
+228
+17% +$3.97K
MTNB icon
3586
Matinas BioPharma
MTNB
$1.55M
$18K ﹤0.01%
585
UTRS
3587
DELISTED
Minerva Surgical, Inc. Common Stock
UTRS
$18K ﹤0.01%
1,167
LAB icon
3588
Standard BioTools
LAB
$326M
$17K ﹤0.01%
15,452
PXLW icon
3589
Pixelworks
PXLW
$38.8M
$17K ﹤0.01%
+892
New +$21.3K
FUV
3590
DELISTED
Arcimoto, Inc. Common Stock
FUV
$17K ﹤0.01%
647
-90
-12% -$4.49K
SOLO
3591
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
$17K ﹤0.01%
13,952
-2,652
-16% -$3.85K
PRTY
3592
DELISTED
Party City Holdco Inc.
PRTY
$17K ﹤0.01%
10,783
-28,000
-72% -$47K
CCO icon
3593
Clear Channel Outdoor Holdings
CCO
$1.23B
$16K ﹤0.01%
12,021
UBX
3594
DELISTED
Unity Biotechnology
UBX
$16K ﹤0.01%
4,301
+3,014
+234% +$19K
MBIO icon
3595
Mustang Bio
MBIO
$4.26M
$15K ﹤0.01%
44
+18
+69% +$8.34K
LITS
3596
Lite Strategy Inc
LITS
$33.6M
$15K ﹤0.01%
2,005
CKPT
3597
DELISTED
Checkpoint Therapeutics
CKPT
$14K ﹤0.01%
1,440
GLDG
3598
GoldMining Inc
GLDG
$179M
$14K ﹤0.01%
18,032
-2,900
-14% -$2.66K
CTSO icon
3599
Cytosorbents Corp
CTSO
$22.6M
$13K ﹤0.01%
10,129
-885
-8% -$1.73K
DRRX
3600
DELISTED
DURECT Corp
DRRX
$13K ﹤0.01%
2,296

Similar funds

Commonwealth Equity Services's Q3 2022 Portfolio in Review

As of Q3 2022, Commonwealth Equity Services held 3,828 positions worth $38.8B, up 1.1% from $38.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Commonwealth Equity Services deployed $1.27B of net new capital in Q3 2022, opening 166 new positions and adding to 1,856 existing holdings. Its largest new stake was Avantis US Large Cap Value ETF: 392,662 shares worth $17.4M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $53.5M trimmed.

  • Commonwealth Equity Services's largest Q3 2022 buy was Avantis US Large Cap Value ETF: 392,662 shares worth $17.4M.
  • Commonwealth Equity Services added most to iShares Core S&P 500 ETF in Q3 2022, an estimated $101M increase.
  • Commonwealth Equity Services's biggest Q3 2022 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $53.5M.
  • Commonwealth Equity Services fully exited FolioBeyond Alternative Income and Interest Rate Hedge ETF in Q3 2022, selling an estimated $2.83M.
  • Commonwealth Equity Services's ten largest holdings make up 20% of its $38.8B portfolio in Q3 2022.
  • Commonwealth Equity Services opened 166 new positions and closed 165 in Q3 2022.
  • Commonwealth Equity Services's portfolio value rose 1.1% quarter-over-quarter to $38.8B.

Based on Commonwealth Equity Services's 13F filing for Q3 2022, filed 14 Nov 2022.